Cargando…
Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases
Autores principales: | Colella, Pasqualina, Meneghini, Vasco, Baldo, Guilherme, Gomez-Ospina, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359423/ https://www.ncbi.nlm.nih.gov/pubmed/37484653 http://dx.doi.org/10.3389/fgeed.2023.1248904 |
Ejemplares similares
-
Prime editing in hematopoietic stem cells—From ex vivo to in vivo CRISPR-based treatment of blood disorders
por: Wolff, Jonas Holst, et al.
Publicado: (2023) -
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System
por: Meneghini, Vasco, et al.
Publicado: (2021) -
In vivo and in vitro genome editing to explore GNE functions
por: Ilouz, Nili, et al.
Publicado: (2022) -
Editorial: Targeted Genome Editing in Crops
por: Zhou, Huanbin, et al.
Publicado: (2021) -
Editorial: Insights in genome editing tools and mechanisms: 2022
por: Jiang, Chanjuan, et al.
Publicado: (2023)